Christmas is one of the most celebrated festivals in the world and its charm comes from the way different traditions blend together. The story of Jesus, the joy of Santa Claus, and the beautiful ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

How do you like your Christmas lights? We all have our preferences, and we’re spoiled for choice, making it easy to decorate our trees exactly the way we want. You can pick white lights, multi-color ...

Portland has sparked outrage after stripping its Christmas tree of its name, referring to it only as “the tree” during its lighting ceremony. As thousands gathered in Pioneer Courthouse Square for the ...

Darkseid's Family Tree Explained in 2 Minutes! #shorts #darkseid #dccomics #dcuniverse Accusations of "sedition" spark uproar. Here's what the law says. Argentina’s $20B Bailout Plan Collapses Grocery ...

TV viewers first met the Targaryens in HBO's "Game of Thrones" and have gone deeper with the silver-haired dragon riders in the saga's prequel series, "House of the Dragon." However, those who've read ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Ayyoun is a staff writer who loves all things gaming and tech. His journey into the realm of gaming began with a PlayStation 1 but he chose PC as his platform of choice. With over 6 years of ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...